Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 5Colorectal Neoplasms 4Hematopoietic and Lymphatic System Neoplasm 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psychological Well-Being 1Prostatic Neoplasms 1Neoplasms 1Cardiovascular Diseases 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Screening 1

Interventions

Cisplatin 23pembrolizumab 21Carboplatin 13Paclitaxel 12Radiotherapy 11Brachytherapy 11Drug Therapy 10Bevacizumab 10Blood Specimen Collection 7Injections 6Colposcopy 6Specimen Handling 5toripalimab 4Taxes 4Surveys and Questionnaires 4Nivolumab 4Mass Screening 4Human Papillomavirus DNA Tests 4Gemcitabine 4Chemotherapy, Adjuvant 4Chemoradiotherapy 4spartalizumab 3lenvatinib 3camrelizumab 3aldesleukin 3Restraint, Physical 3Radiation 3Fulvestrant 3Cyclophosphamide 3Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Uterine Cervical Neoplasms × Patient Navigation × Clear all
NCT06666192 2025-12-24

The Ohio State University (OSU) SCREEN Community Program

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
2,067 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡